ACT Venture Capital
Seed–Series B
What they invest in
from 1 of 1 portfolio companiesAI & Machine Learning ×1B2B Marketplaces ×1Enterprise Software ×1SaaS ×1
HQs:Ireland×1
Investments · 1 tracked
founders shown can be your intro pathKeelvar is an AI-native advanced sourcing optimization platform that helps enterprises automate and optimize procurement processes by matching buyers and suppliers fairly using intelligent algorithms. The software serves multinationals and procurement teams managing large-scale B2B sourcing operations.
AI & Machine LearningB2B MarketplacesEnterprise SoftwareSaaSCork, IE
Alan Holland(Founder & CEO)
Frequently asked questions
- What stage does ACT Venture Capital invest at?
- ACT Venture Capital invests at the Seed, Series A, Series B stages.
Similar investors
500 Global's Sustainable Growth practice designs and implements sovereign-aligned strategies that unlock resilient, inclusive, and sustainable economic growth across the Global Majority—Asia, Africa, Latin America, and the Middle East. The practice bridges public priorities and private capital through ecosystem development, blended finance, and localized innovation programs addressing health, agriculture, gender, climate, and education.
a16z is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz that invests in seed through growth-stage technology companies across multiple sectors including AI, healthcare, consumer, crypto, enterprise, fintech, and gaming. The firm manages over $100 billion in assets and operates a distinctive platform model with a large team of operators supporting founders throughout their journey.
August Capital is a venture capital firm headquartered in the San Francisco Bay Area that has invested in early-stage startups across information technology since 1995. The firm manages approximately $2 billion in assets and combines capital deployment with operational support and networking assistance to help entrepreneurs build successful companies.
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.